Leadership

 

 

Vice President for Research, Leo M. Chalupa

Leo M. Chalupa became the university’s first vice president of research on April 1, 2009. He serves as GW’s chief research officer, charged with overseeing the strategic and operational development of our rapidly growing research enterprise.

An accomplished scientist and administrator, Dr. Chalupa comes to GW following a 34-year career at the University of California, Davis, most recently serving as the chair of neurobiology, physiology and behavior in the College of Biological Sciences. A distinguished professor of neurobiology and ophthalmology at UC Davis, he founded the university’s Center for Neuroscience in 1992, as well as the Mind and Brain Center, the Brain Imaging Center and the Center for Visual Sciences.

Interim Associate Vice President for Research, Gina M. Lohr

Gina Lohr is the Interim Associate Vice President for Research. Gina has served in multiple roles within OVPR, most recently as Assistant Vice President for Research. She is a Certified Research Administrator and has more than 12 years of experience in academic research administration at the George Washington University (GW).
 
Gina’s portfolio includes overseeing the Office of Sponsored Projects and its Research Enhancement Unit, management of core facilities, data management and analysis, human resources, budgeting, cross-disciplinary research initiatives, communications, systems innovation and overall OVPR operations.
 
Gina has served as a member of the GW Committee on Classification and Compensation, the GW President’s Council on Diversity and Inclusion, the university’s Sexual Assault Prevention and Response committee, the university’s Benefits Advisory Committee, and the planning committee for the grand opening of the Science and Engineering Hall.
 
Gina is an active volunteer with organizations that support survivors of sexual assault.

 

 

 

 

Associate Vice President, Research Integrity, Sheila Garrity

Sheila Garrity joined OVPR in June, 2014 and is tasked with providing highly visible and responsible leadership in the development and administration of institutional policies, procedures and programs as they relate to research integrity and compliance.  She will partner with key stakeholders around the institution to develop a strong research integrity infrastructure.  In her role, she oversees the operations of the Office of Laboratory and Radiation Safety; the Office of Human Research; the Animal Research Facilities; and Regulatory Affairs.

Ms. Garrity is a national leader in the fields of research integrity and the responsible conduct of research education.  She comes to us after spending over 20 years at Johns Hopkins University School of Medicine where she most recently served as the Director of the Division of Research Integrity.  Ms. Garrity earned her MBA and MPH at Johns Hopkins where she also received a Certificate in Health and Human Rights and her JD from the University of Maryland School of Law.

Associate Vice President for Clinical and Translational Research, Lisa M. Guay-Woodford, M.D.

Lisa Guay-Woodford, MD is an internationally recognized expert in the field of polycystic kidney disease. Her major research effort focuses on identifying the genetic factors involved in the pathogenesis of autosomal recessive polycystic kidney disease (ARPKD). 

Dr. Guay-Woodford has a dual appointment at GW and Children's National Medical Center as the Director of the Center for Translational Science.  She also serves as the Principal Investigator and Director of the Clinical and Translational Science Institute at Children's National (CTSI-CN).


 

 

 

 

 

 

Assistant Vice President for Corporate and Industry Research, Thomas P. Russo

Thomas P. Russo became OVPR’s first Assistant Vice President for Corporate Industry Research in October, 2012. He is tasked with forging partnerships with private companies and foundations to fund research and other special projects and initiatives at GW. He works closely with faculty in GW research centers and institutes who are looking to connect their innovative research projects with industry leaders.  Tom also works closely with GW’s Office of Innovation & Entrepreneurship to help develop and commercialize technologies initiated at GWU.

Before coming to GW, Russo spent over 20 years cultivating relationships between private companies and the public sector. He was the Chief Financial Officer for both public and private corporations and helped found many start-up companies, many of which are highly successful today. As Chief Financial Officer, he managed licenses, patents, and contracts with major university for research grants and intellectual property and successfully raised over $200m in equity. Prior to his corporate roles, Tom worked at the World Bank (IBRD)and its private sector affiliate, the International Finance Corporation (IFC) where he was responsible for providing debt/equity funding for major projects in the energy, industrial and tech sectors. Russo received his BA in Government and Foreign Service from Georgetown University and his MBA in International Business and Finance from GW.

 

 

 

 

 

 

Associate Vice President, Innovation and Entrepreneurship, James Chung

Jim Chung is the executive director of the Office of Innovation & Entrepreneurship, where he is responsible for entrepreneurship programs. As the director of the Mtech VentureAccelerator at the University of Maryland before joining the George Washington University, Jim worked with faculty and students there to launch startup companies based on University of Maryland technology.

Prior to that, he served as the director of new business development at the Corporate Executive Board and helped establish the company’s mergers and acquisitions capabilities. He also served as vice president at Cherington Capital (now Intervale Capital), a middle market private equity firm. He started his private sector career as an early stage venture capital investor, most recently at incTANK Ventures, where he was the managing director. Before becoming an investor, Jim was an academic researcher studying how business, government, and academia work together to create new innovations in high technology industries. He was a research fellow at MIT (Security Studies Program), Harvard (Center for Science and International Affairs), the University of Tokyo (Fulbright Fellow), and the Korea Advanced Institute of Science and Technology (NSF Fellow). He received his Bachelor and Masters degrees from Stanford University and was a Ph.D. candidate at MIT.

 

 

 

 

 

 

 

 

 

 

Managing Director, Technology Commercialization Office, Steven Kubisen
 
Steve is a serial entrepreneur, corporate executive and university technology commercialization executive. He started his career in research and then moved to research management and general management for Union Carbide, Akzo Coatings, GE and Alcoa.  During his eight years with GE, as General Manager of GE Electromaterials, he commercialized a revolutionary circuit board material for the emerging computer and telecommunications industries and as General Manager of R&D and Engineering of the $500M GE Silicones Division instituted systems to double new product sales.  
 
As an entrepreneur, Steve was CEO of a revolutionary composite manufacturing venture and a medical device venture, in addition to serving on boards of a number of early stage ventures. Steve’s passion for commercializing early technologies and growing entrepreneurial communities led him to university technology commercialization operations. 
 
For over seven years, he served as Vice President of Utah State University’s Office of Technology Commercialization and Senior Director of Ventures and the Medical Device/Software/Engineering Portfolio Group at the Johns Hopkins University. During his four year tenure at Utah State, Steve tripled licensing revenue and moved the institution into the top five in the nation for start-ups per research dollar.  During his three year tenure at Hopkins, the institution increased start-ups from a historical annual level of four to 12 in 2008, with $76M venture capital raised. 
 
Steve has an A.B. in chemistry from Cornell University and a Ph.D. in organic chemistry from Harvard University.